Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants

At present, the safety and regulatory hurdles that will be encountered with the addition of novel immune potentiators and delivery systems to final vaccine formulations may be significant and are still largely ill defined.

also in 13,097 other papers